
Last updated: 2026-09-10 09:10:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Prestige Consumer Healthcare Inc. (PBH) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $49.00, with a market capitalisation of $2.36B and a P/E ratio of 13.41. Over the past 52 weeks, its price has ranged from $42.62 to $71.07. This page covers its latest market performance, valuation, price trends and company information.
$2.36B | |
$49.00 | |
$90.04 | |
$3.92 | |
$48.70 | |
595.00 | |
571.63K | |
13.41 | |
$71.07 | |
$42.62 | |
-- | |
-- |
Prestige Consumer Healthcare Inc. (PBH) is trading at $49.00 in pre-market trading as of 2026-09-10 08:21:24, up 0.62% ($0.30) from the previous close of $48.70
Pre-market trading shows how investors are pricing PBH before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Prestige Consumer Healthcare Inc. (PBH) moved from $51.78 to $49.00, representing a decline of 5.37% ($2.78).
The stock traded between $48.17 and $53.95 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 455.72 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 22.4%
PBH is currently trading at $49.00, placing it 22.4% of the way from its 52-week low of $42.62 to its 52-week high of $71.07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 890 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Prestige Consumer Healthcare Inc. (PBH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.